| Name | Title | Contact Details |
|---|
HealthTrio LLC is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
Cedar provides a smarter way for hospitals, health systems and medical groups to manage the patient payment ecosystem. Our platform delivers modern intelligence to alleviate collections challenges, dramatically improve billing operations and ensure a personalized billing experience for patients. Most revenue cycle solutions today look at only one or two transactional aspects of patient payments. We believe that the focus instead should be on improving the overall experience of patient billing and engagement. Together with the leading medical groups and hospitals across the country, we are elevating the patient payment experience.
Sensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally-invasive, and cost-effective treatments for both oncological and non-oncological conditions. Offering proprietary low-energy X-ray technology known as superficial radiation therapy (SRT), which is the culmination of more than a decade of research and development, to treat non-melanoma skin cancers and keloids with its SRT-100™, SRT-100+™ and SRT-100 Vision™ systems. With its portfolio of innovative medical device products, Sensus provides revolutionary treatment options to enhance the quality of life of patients around the world. The Sculptura™ robotic radiation oncology system provides targeted intraoperative triple-modulated radiotherapy (IORT) and Brachytherapy utilizing our proprietary, state-of-the-art 3D Beam Sculpting™ to treat patients undergoing cancer treatment during surgery, or at the tumor site, with a single dose. Sensus Smart Lasers powered by Sentinel is the worlds first ever Smart Lasers. Data Backup, Remote Monitoring for 5 aesthetic lasers.
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs. FibroGen’s research team is committed to discovering novel therapies in areas of major unmet medical need. Our goal is to continue to provide pipeline candidates supported by rigorous data in well-characterized therapeutic settings. All of FibroGen`s therapeutic candidates have been internally developed based on FibroGen`s pioneering research in two important areas of biology, hypoxia-inducible factor (HIF) and connective tissue growth factor (CTGF).
Green River Regional Mental Health Mental Retardation Board Inc is a Owensboro, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.